Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.4.0.3
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 4,253,931 $ 5,486,526
Short-term investments 294,875 294,802
Accounts receivable, net 5,888,310 5,286,863
Unbilled revenue 859,270 1,072,391
Inventory, net 5,301,532 5,683,043
Due from related party 594,599 1,177,261
Prepaid and other current assets 354,891 353,105
Total current assets 17,547,408 19,353,991
Property, plant and equipment, net 549,319 543,754
Intangible assets, net 1,048,280 1,044,611
Goodwill 40,870 40,870
Other assets 58,425 58,425
TOTAL ASSETS 19,244,302 21,041,651
Current liabilities:    
Accounts payable 2,377,211 3,311,809
Accrued expenses 1,079,969 1,066,860
Deferred revenue 984,239 996,941
Total current liabilities 4,441,419 5,375,610
Long-term liabilities:    
Deferred revenue, net of current portion 322,885 273,162
Senior convertible promissory note, related party 2,963,393 2,951,011
Total liabilities $ 7,727,697 $ 8,599,783
Commitments and contingencies
Tecogen Inc. shareholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized; 18,478,990 issued and outstanding at March 31, 2016 and December 31, 2015 $ 18,479 $ 18,479
Additional paid-in capital 34,522,237 34,501,640
Accumulated deficit (22,575,605) (21,682,437)
Total Tecogen Inc. stockholders’ equity 11,965,111 12,837,682
Noncontrolling interest (448,506) (395,814)
Total stockholders’ equity 11,516,605 12,441,868
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 19,244,302 $ 21,041,651